A Vaccine (VSV-hIFNβ-NIS) With or Without Cyclophosphamide and Combinations of Ipilimumab, Nivolumab, and Cemiplimab in Treating Relapsed or Refractory Multiple Myeloma, Acute Myeloid Leukemia or Lymphoma
Mayo Clinic
Mayo Clinic
City of Hope Medical Center
UNC Lineberger Comprehensive Cancer Center
Barbara Ann Karmanos Cancer Institute
UNC Lineberger Comprehensive Cancer Center
City of Hope Medical Center
Rutgers, The State University of New Jersey
Northwestern University
Barbara Ann Karmanos Cancer Institute
M.D. Anderson Cancer Center
Jonsson Comprehensive Cancer Center
Jonsson Comprehensive Cancer Center
Case Comprehensive Cancer Center
Canadian Cancer Trials Group
Barbara Ann Karmanos Cancer Institute
Mayo Clinic
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
University of Wisconsin, Madison
National Cancer Institute (NCI)
Roswell Park Cancer Institute
Roswell Park Cancer Institute
Takeda
Swiss Cancer Institute
Barbara Ann Karmanos Cancer Institute
M.D. Anderson Cancer Center
Wake Forest University Health Sciences
Wake Forest University Health Sciences
Ohio State University Comprehensive Cancer Center
Ohio State University Comprehensive Cancer Center
European Organisation for Research and Treatment of Cancer - EORTC
University of California, San Francisco
Fred Hutchinson Cancer Center
Wake Forest University Health Sciences
Wake Forest University Health Sciences
Massachusetts General Hospital
Fred Hutchinson Cancer Center
University of Washington
Fred Hutchinson Cancer Center
Fred Hutchinson Cancer Center
Vanderbilt University Medical Center
Mayo Clinic
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)
Rutgers, The State University of New Jersey
Alliance for Clinical Trials in Oncology